Revolution Medicines Inc
Revolution Medicines Inc (RVMD) Unusual Options Activity Today
RVMD options volume power reached 91x on the previous trading day. The highest reading was on the $100 PUT expiring 2026-10-16.
Read more
Checking RVMD unusual options activity helps you spot when traders are making outsized bets on Revolution Medicines Inc before the broader market catches on. Revolution Medicines Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor RVMD unusual options activity today and surface the prints that deserve a second look.
Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching RVMD unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking RVMD unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and RVMD unusual options flow data becomes especially valuable around earnings, product launches, and macro events.
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also develops RMC-5845, a selective inhibitor of SOS1, a protein that converts RAS (OFF) to RAS (ON) in cells; and RMC-5552, a hyperactivated selective inhibitor of mTORC1 signaling in tumors. In addition, the company is developing RMC-6291, a mutant-selective inhibitor of KRASG12C(ON) and NRASG12C(ON); and RMC-6236, a RAS-selective inhibitor of multiple RAS(ON) variants.
Further, it develops RAS(ON) Inhibitors targeting KRASG13C(ON) and KRASG12D(ON). The company has a collaboration agreement with Sanofi for the research and development of SHP2 inhibitors, including RMC-4630. Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.
Catalysts rarely arrive without a footprint, and RVMD unusual options activity is often where that footprint shows up first. Our scanner tracks Revolution Medicines Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at RVMD unusual options volume on the call side or chasing put sweeps, Revolution Medicines Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.
| 240.00 | 0.20 | 0.60 | 0.40 | 45% | 18 | 282 | 6.38% |
| 220.00 | 1.90 | 3.20 | 2.55 | 44% | 33 | 638 | 5.17% |
| 185.00 | 20.80 | 24.10 | 22.45 | 52% | 11 | 213 | 5.16% |
| 160.00 | 44.40 | 47.80 | 46.10 | 73% | 1 | 21 | 4.76% |
| 210.00 | 4.20 | 6.20 | 5.20 | 42% | 40 | 843 | 4.75% |
| 200.00 | 2.50 | 5.50 | 4.00 | 38% | 99 | 252 | 39.29% |
| 195.00 | 1.10 | 4.90 | 3.00 | 43% | 7 | 126 | 5.56% |
| 180.00 | 0.05 | 2.15 | 1.10 | 52% | 4 | 106 | 3.77% |
| 190.00 | 1.25 | 3.80 | 2.53 | 49% | 7 | 228 | 3.07% |
| 210.00 | 7.50 | 11.00 | 9.25 | 40% | 3 | 142 | 2.11% |
As of September 30, 2026
Spot unusual options activity before it moves
Track RVMD options flow across every expiration, filter by volume power, and find the setups with abnormal activity before the trade is gone.
Start your 14-day free trial→